Anteris Technologies Ltd (AVR.AX)

21.29 -0.01 (-0.05%) At close: 03:59PM AEST

Anteris Technologies Ltd

Toowong Tower
Suite 302 Level 3 9 Sherwood Road
Toowong, QLD 4066
Australia
61 13 0055 0310
https://www.anteristech.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Wayne Geoffrey Paterson	CEO, MD & Executive Director	1.93M	N/A	1967
Mr. Matthew McDonnell	Chief Financial Officer	548.77k	N/A	N/A
Mr. David St. Denis	Chief Operating Officer	1.07M	N/A	N/A
Mr. Stephen Denaro	Independent Non-Executive Director & Company Secretary	221.6k	N/A	N/A
Dejan Toracki	Corporate Development Director	N/A	N/A	N/A
Dr. Chris Meduri M.D., M.P.H.	Chief Medical Officer & Member of Medical Advisory Board	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Anteris Technologies Ltd, a structural heart company, designs, develops, and commercializes medical devices. The company manufactures and sells ADAPT, a regenerative tissue product. Its lead product is the DurAVRTM, a transcatheter heart valve for the treatment of aortic stenosis. The company was formerly known as Admedus Limited and changed its name to Anteris Technologies Ltd in May 2020. Anteris Technologies Ltd was incorporated in 1999 and is based in Toowong, Australia.

Corporate governance

Anteris Technologies Ltd’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.